In a class action lawsuit, the individuals or plaintiffs who file the lawsuit serve as “class representatives,” bringing claims on behalf of themselves and other people with similar allegations. This group is known as the “class,” and individuals included in it are referred to as “settlement class members.” A single court addresses and resolves the legal issues for all class members, except for those who choose to exclude themselves by following the specified opt-out procedures.

Plaintiffs and Monsanto have agreed to this settlement to avoid the substantial risks and uncertainty of continued litigation. Class Counsel and the Class Representatives support the settlement in light of two significant risks that could result in no recovery if the cases proceed:

• Preemption Risk: The U.S. Supreme Court could determine that federal law overrides (or “preempts”) these claims because the EPA approved Roundup’s product labeling. If the Court rules in Monsanto’s favor, many or most claims could be dismissed.
• Bankruptcy Risk: Monsanto is facing financial pressures that could potentially lead to bankruptcy. If that were to occur, claims could be delayed for years and any recovery could be significantly reduced—or unavailable altogether.

Non-Hodgkin’s lymphoma (NHL) is a type of cancer that begins in white blood cells known as lymphocytes. Lymphocytes are an essential part of the immune system and help the body defend itself against infections and other diseases.

• Non-Hodgkin’s lymphoma (NHL), including Hairy Cell Leukemia and Aggressive NK-Cell Leukemia.
• Any leukemia identified under the World Health Organization Classification of Tumours – Haematolymphoid, Volume 11 (Revised 5th Edition, 2024) that includes the terms “lymphoma,” “lymphocytic,” or “prolymphocytic” in its official name.

Claims for persons suffering from the following diseases are not covered under this settlement:

• Hodgkin’s lymphoma.
• Multiple myeloma.
• Leukemias that do not include the terms “lymphoma,” “lymphocytic,” or “prolymphocytic” in their names.

You are part of the settlement if you meet ALL of the following requirements:

• You are a U.S. citizen or a non-U.S. citizen who was residing in the United States on the date of Preliminary Approval;
• You were exposed to Roundup® products in the United States before February 17, 2026—whether by contact, inhalation, ingestion, or absorption; and
• Your exposure occurred because you:
  • Applied the products yourself;
  • Bought or paid for the products or for their application;
  • Took part in, directed, or observed the application of the products; or
  • Otherwise had reason to be aware that you were exposed.

Note: For purposes of this settlement, “United States” includes all 50 states, the District of Columbia, Puerto Rico, Guam, American Samoa, the U.S. Virgin Islands, the Northern Mariana Islands, any other U.S. territories, and U.S. military or diplomatic installations worldwide.

You are NOT included in the settlement if any of the following apply:

• You were exposed to Roundup® products but are alleging injuries other than Non-Hodgkin Lymphoma (NHL);
• You are a judge or member of court staff assigned to this case;
• You are a current or former officer, director, or employee of Monsanto or any of its subsidiaries as of the date of Preliminary Approval;
• You only observed someone else applying Roundup® products and were unaware that the products were weed killers;
• You have already resolved your claim with Monsanto and signed a release;
• Your claim was previously dismissed by a court with prejudice (meaning it was permanently dismissed); or
• You have a claim pending in the federal multidistrict litigation, In re Roundup® Products Liability Litigation, MDL No. 2741, as of the date of Preliminary Approval. (If you voluntarily dismiss your MDL claim, you may request to participate in this settlement.)

If you are included in the settlement, you will be categorized based on your diagnosis status and exposure type.

• Diagnosed with NHL
  SUBCLASS 1
  You were diagnosed with non-Hodgkin lymphoma (NHL) as of the date of preliminary approval of the settlement and meet the exposure requirements.
• Not Yet Diagnosed
  SUBCLASS 2
  You meet the exposure requirements but have NOT been diagnosed with NHL. You are part of the settlement now, but you can only submit a claim for compensation if you are diagnosed with NHL in the future.

Occupational vs. Residential Claimants:
Understanding your classification helps determine your potential settlement benefits.

• Occupational Claimant:
  • Exposed to Roundup Products for more than 80 hours while working in an agricultural, industrial, turf, or ornamental job, AND,
  • Earned more than 50% of your income or more than $15,000 from this job in at least one year.
• Residential Claimant:
  • You were exposed to Roundup Products in a residential capacity.
  • You do not meet the hours or income requirements for an Occupational Claimant.

For more details on occupational vs residential claimants, click here.

Derivative and Representative Claimants:

• Derivative Claimants: You may qualify as a Derivative Claimant if you are the spouse, parent, or dependent child of a class member, or if you have another legally recognized relationship that gives you the right to bring a claim based on that person’s exposure to Roundup® products.
• Representative Claimants: You may qualify as a Representative Claimant if you are acting in a legal capacity—such as a legal representative, executor, or administrator—on behalf of a person who was exposed to Roundup® products and is now deceased or legally incapacitated.

The settlement will pay claims for 17 to 21 years. Your award depends on your exposure type, diagnosis, and the age at which you were diagnosed.

For details on potential settlement awards, click here for details.

If you have already been diagnosed with NHL:

• You must submit a Registration Form to the Settlement Administrator within 180 days after the Court grants Final Approval of the settlement (the earliest this period could begin is the date of Preliminary Approval).
• You must also submit a complete Claim Package, including required medical documentation/proof, no later than 180 days after the Effective Date (the date the settlement becomes final and no longer subject to appeal).
• File a claim within 180 days after all appeals are resolved.

If you are diagnosed with NHL in the future:

• You are not required to submit a Registration Form.
• You must submit a complete Claim Package within six years of your NHL diagnosis and before the 16th year following the start of the settlement program.

Claims and registrations may be submitted online at www.WeedKillerClass.com.

Note: If you are represented by an attorney, your attorney may submit the required forms and documentation on your behalf.

The specific calendar deadlines will be posted on the settlement website after the Court approves the settlement.